Ocain Tim 4
4 · ENANTA PHARMACEUTICALS INC · Filed Nov 21, 2017
Insider Transaction Report
Form 4
Ocain Tim
Senior Vice President
Transactions
- Award
Stock Option (right to buy)
2017-11-17+21,500→ 21,500 totalExercise: $48.52Exp: 2027-11-17→ Common Stock (21,500 underlying)
Footnotes (1)
- [F1]Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 17, 2017).